CTRI/2009/091/000731已完成1 期
Double blind, Randomized, Placebo Controlled Single Center, Prospective Study to Evaluate Efficacy and Safety of AG Arbutin Cream in Skin Lightening (Melanin Reduction) In Healthy Subjects.
Piramal Life Sciences Limited Mumbai0 个研究点目标入组 36 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy male and female subjects (based on medical history and general examination) within 18 ? 55 years of age
- •2.Healthy subjects with no prior history of skin disease or skin related problems in past six months
- •3.Subjects willing to give written informed consent and willing to follow up regularly for entire duration of the study
排除标准
- •1.Subjects who are on any medication for skin disorder or applying any topical
- •medication (including cosmetic) to left forearm during the duration of study.
- •2.Pregnant and lactating females
- •3.Subjects receiving steroids, retinoids, non-steroidal anti-inflammatory drugs or
- •any other drugs causing hyperpigmentation or used for the treatment of hyperpigmentation (Refer to Appendix A: Drugs causing hyperpigmentation & Drugs used for the treatment of hyperpigmentation)
- •4.Subject who has participated in any clinical trial in the past 4 weeks
研究者
相似试验
已完成
不适用
Double-Blind, Randomized, Placebo-Controlled, Mono-Centre Pilot (Proof-of-Concept) Study to Investigate the Effect of IMPP-1 on Immune Functions That Contribute to Resistance to (Respiratory) Infection in Healthy SubjectsHealthy SubjectsDRKS00010568Chief Executive Officer, NutriLeads B.V.60
进行中（未招募）
不适用
Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N acetylcysteine on small airways and on inflammation and oxidative stress in COPD patientsChronic Obstructive Pulmonary DiseaseEUCTR2007-003946-13-BEniversity Hospital Antwerp; Department Respiratory Medicine
进行中（未招募）
1 期
Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N-acetylcysteine on small airways and on inflammation and oxidative stress in COPD patientsChronic Obstructive Pulmonary DiseaseEUCTR2008-006837-28-BEniversity Hospital Antwerp; Department Respiratory Medicine
进行中（未招募）
不适用
Double blind, randomized, placebo-controlled, parallel group study to evaluate the effect of a 4-week treatment with oral doses of MEN15596 in irritable bowel syndrome. - Not applicableIrritable Bowel Syndrome.MedDRA version: 9.1Level: LLTClassification code 10023003Term: Irritable bowel syndromeEUCTR2008-000214-71-LVaboratorios Menarini S.A. (Menarini Group)620
进行中（未招募）
1 期
Double blind, randomized, placebo-controlled, parallel-group, multicenter/multinational, efficacy and safety study of desloratadine 5 mg in the treatment of subjects with allergic rhinitis who meet the criteria for Intermittent Allergic Rhinitis IAR . - NDEUCTR2005-005449-20-ITSCHERING-PLOUGH547